Predigen Can Accurately Predict Respiratory Viral Infection
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients Predigen Developing Diagnostic Tools Designed to Help Physicians Differentiate Bacterial from Viral Infections and Detect Acute Respiratory Illness Early …
Newly published data shows positive results in KRYSTEXXA trial
MIRROR Open-Label Trial Data Published in Journal of Rheumatology Show 79 Percent of Patients Achieved a Complete Response Using KRYSTEXXA® (pegloticase injection) with Methotrexate — Data adds to growing body of evidence on immunomodulation with KRYSTEXXA and emerging…
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
September 08, 2020 07:30 AM Eastern Daylight Time DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with…
Duke startup inSoma Bio looking to raise $1M
by WRAL TechWire — September 4, 2020 . DURHAM — Biotech startup InSoma Bio has raised $50,000 in security, according to a filing with the US Securities and Exchange Commission. One investor contributed to the round, which kicked off on…
Sophisticated Modeling Boosts Split Ventilators to Emergency FDA Review
Researchers at Duke University have engineered a workaround to make ventilators safer and more efficient when splitting them between patients. With a set of biocompatible 3D-printed parts to control the amount of air being pushed…
Immunomic Therapeutics Announces Publication of Results from 3 ATTAC Studies
Sept. 1, 2020 12:05 UTC Immunomic Therapeutics Announces Publication of Results from 3 ATTAC Studies of CMV-Specific Dendritic Cell Vaccines for the Treatment of GBM ~25-35 % survival over 5 years from diagnosis in vaccinated…
Duke Institute Tapped to Test Monoclonal Antibody Preventative for COVID-19
DURHAM, N.C. — The Duke Human Vaccine Institute Pandemic Prevention Program (DHVI-P3) has received an additional $7.6 million in federal funding to manufacture and test in humans a neutralizing monoclonal antibody for the prevention of COVID-19. The…
Three NC life science execs crack PharmaVoice ‘most inspiring’ list
Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry. Named to PharmaVoice 100 are PPD’s Karen Kaucic, M.D., the company’s chief…
Public company Precision BioSciences, Inc. earns key designation for leukemia treatment
The Durham drugmaker has received fast-track designation from regulators for its leukemia drug, meaning approval of the treatment could roll through its pipeline faster. Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated…